https://pixabay.com/en/tablets-pharmacy-medications-cure-2248375/

New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients

Post author:Scott Carlson
Post published:August 8, 2019
Post category:Rare Disease

According to a publication from ScienceDaily, a new study of propranolol suggests explanations for its ability to shrink certain benign tumors in infants and relieve symptoms of hypotrichosis-lymphedema-telangiectasia syndrome. About…

Share Your Story

February is RARE DISEASE MONTH! Patient Worthy believes that every rare story deserves to be told. Click below to tell us yours.

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Share Your Story

New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Share Your Story

Let’s Work Together!

Keep Up to Date

Learn More